Laven Pharma India Private Limited, a active private limited company, was established on 27 January 2005 in Chennai, Tamil Nadu, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24231TN2005PTC055230. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Harakishore Tadiparthy (Whole-Time Director), Kishan Babu Tadiparthi (Director). Past directors included Koteswari Tadiparthi, Tadiparthy Venkata Rao. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1/270A, Mangadu Main Road, Sathyanarayanapuram, Chandramouleeswar Nagar, Moulivakkam, Chennai, Tamil Nadu, 600116.
U24231TN2005PTC055230
055230
27 January 2005
₹1.00 M
₹1.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Laven Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harakishore Tadiparthy | Whole-Time Director | 27 Jan 2005 | Current |
| Kishan Babu Tadiparthi | Director | 27 Jan 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Oct 2023 | Past |
| Pramod Abcsdd | Director | 21 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Laven Pharma India Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.24% increase. The company also saw a substantial improvement in profitability, with a 17.89% increase in profit. The company's net worth Soared by an impressive increase of 13.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Laven Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2012 | The Karur Vysya Bank Limited | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Laven Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Laven Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laven Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Laven Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Laven Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity A charge with The Karur Vysya Bank Limited amounted to Rs. 2.00 M with Charge ID 10343989 was registered on 07 Feb 2012. was completed.
The activity Harakishore Tadiparthy was appointed as a Whole-time director was appointed as a Whole-time director on 27 Jan 2005 & has been associated with this company since 20 years 10 months . was completed.
Kishan Babu Tadiparthi was appointed as a Director was appointed as a Director on 27 Jan 2005 & has been associated with this company since 20 years 10 months . was recorded as a recent event.
The activity Laven Pharma India Private Limited was registered on 27 Jan 2005 with Roc Chennai & aged 20 years 10 months as per MCA records. was completed.
The CIN of Laven Pharma India Private Limited is U24231TN2005PTC055230.
Laven Pharma India Private Limited is headquartered at 1/270A, Mangadu Main Road, Sathyanarayanapuram, Chandramouleeswar Nagar, Moulivakkam, Chennai, Tamil Nadu, 600116.
Laven Pharma India Private Limited was incorporated on 27 January 2005.
The current directors of Laven Pharma India Private Limited are
The primary industry of Laven Pharma India Private Limited is Manufacturing.
Laven Pharma India Private Limited is unlisted.
The authorized capital of Laven Pharma India Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Laven Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX